| Literature DB >> 15299283 |
Laurent Grossin1, Stéphanie Etienne, Nadège Gaborit, Astrid Pinzano, Christel Cournil-Henrionnet, Catherine Gerard, Elisabeth Payan, Patrick Netter, Bernard Terlain, Pierre Gillet.
Abstract
The aim of this work was to determine whether Hsp70 overexpression via proteasome inhibitor MG132 was able to protect chondrocytes towards mono-iodoacetate (MIA) cytotoxicity both in vitro and in vivo. In vitro, overexpression of Hsp70 via MG132 was significantly able to protect chondrocytes from MIA toxicity (MTT/LDH analyses). Hsp70 essentially mediated this chondroprotective effect as demonstrated by antisense strategy. In vivo, chondrocytic overexpression of Hsp70, after a preventive intra-articular injection of MG132 in rat knee, was sufficient to decrease the severity of OA-induced MIA lesions, as demonstrated histologically and biochemically. In conclusion, intracellular overexpression of Hsp70, through proteasome inhibition, could be an interesting tool in protecting chondrocytes from cellular injuries, either necrotic or apoptotic in nature, and thus might be a novel chondroprotective modality in rat experimental OA.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15299283
Source DB: PubMed Journal: Biorheology ISSN: 0006-355X Impact factor: 1.875